References
- Stinson , S. C. 2001 . Chiral phamaceuticals . Chem. Eng. News , 79 ( 40 ) : 79 – 97 .
- Rasor , J. P. and Voss , E. 2001 . Enzyme‐catalyzed process in pharmaceutical industry . Appl. Catal. A: Gen. , 221 ( 1 ) : 145 – 158 .
- Kramer , M. S. , Cutler , N. , Feighner , J. , Srivastava , R. , Carman , J. , Sramek , J. J. , Reines , S. A. , Liu , G. , Snavely , D. , Wyatt‐Knowles , E. , Hale , J. J. and Mills , S. G. 1998 . Distinct mechanism for antidepressant activity by blockade of central substance P receptors . Science , 281 : 1640 – 1645 .
- Hale , J. J. , Mills , S. G. , MacCoss , M. , Finke , P. E. , Cascieri , M. A. , Sadowski , S. , Ber , E. , Chicchi , G. G. , Kurtz , M. , Metzger , J. , Eiremann , G. , Tsou , N. N. , Tattersall , D. , Rupniak , N. M. J. , Williams , A. R. and Rycroft , W. 1998 . Structural optimization affording 2‐(R)‐(1‐(R)‐3,5‐Bis(trifluoromethyl)phenylethoxy)‐3‐(S)‐(4‐fluoro)phenyl‐4‐(3‐oxo‐1,2,4‐triazol‐5‐yl)methylmorpholine, a potent, orally active, long‐acting morpholine acetal human NK‐1 receptor antagonist . J. Med. Chem. , 41 : 4607 – 4614 .
- Hale , J. J. , Mills , S. G. , MacCoss , M. , Shah , S. K. , Qi , H. , Mathre , D. , Cascieri , M. A. , Sadwoski , S. , Strader , C. , MacIntyre , D. E. and Metzer , J. M. 1996 . 2(S)‐((3,5‐Bis(trifluoromethyl)benzyl)oxy)‐3(S)‐phenyl‐4‐((3‐oxo‐l,2,4‐triazol‐5‐yl)methyl)morpholine (1): A potent, orally active, morpholine‐based human Neurokinin‐1 receptor antagonist . J. Med. Chem. , 39 : 1760 – 1762 .
- Zhao , M. M. , McNamara , J. M. , Ho , G. J. , Emerson , K. M. , Song , Z. J. , Tschaen , D. M. , Brands , K. M. J. , Dolling , U. H. , Grabosk , E. J. J. and Reider , P. J. 2002 . Practical asymmetric synthesis of aprepitant, a potent human NK‐1 receptor antagonist, via a stereoselective lewis acid‐catalyzed trans acetalization reaction . J. Org. Chem. , 67 : 6743 – 6747 .
- Brands , K. M. J. , Payack , J. F. , Rosen , J. D. , Nelson , T. D. , Candelario , A. , Huffman , M. A. , Zhao , M. M. , Li , J. , Crig , B. , Song , Z. J. , Tschaen , D. M. , Harisen , K. J. , Devine , P. N. , Pye , P. J. , Rossen , K. , Dormer , P. G. , Reamer , R. A. , Welch , C. J. , Mathre , D. J. , Tsou , N. N. , McNamara , J. M. and Reider , P. J. 2003 . Efficient synthesis of NK1 receptor antagonist aprepitant using a crystallization‐induced diastereoselective transformation . J. Am. Chem. Soc. , 125 : 2129 – 2135 .
- Dorn , C. P. , Finke , P. E. , Hale , J. J. , Gills , S. G. and Williams , B. J. Morpholine and thiomorpholine tachykinin receptor antagonists . US 5,719,147
- Brands , K. M. J. , Krska , S. W. , Rosner , T. , Conrad , K. M. , Corley , E. G. , Kaba , M. , Larsen , R. D. , Reamer , R. A. , Sun , Y. and Tsay , F. 2006 . Understanding the origin of unusual stepwise hydrogenation kinetics in the synthesis of the 3‐(4‐fluorophenyl)morpholine moiety of NK1 receptor antagonist aprepitant . Org. Proc. Res. & Dev. , 10 : 109 – 117 .
- Hansen , K. B. , Chilenski , J. R. , Desmond , R. , Devine , P. N. , Grabowski , E. J. J. , Heid , R. , Kubryk , M. , Mathre , D. J. and Varsolona , R. 2003 . Scalable, efficient process for the synthesis of (R)‐3,5‐bistrifluoromethylphenyl ethanol via catalytic asymmetric transfer hydrogenation and isolation as a DABCO inclusion complex . Tetrahedron Asymm. , 14 : 3581 – 3587 .
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICIH) . Section Q3B: Guidelines on Impurities in New Drug Products via Food and Drug Administration (FDA); web site‐ http://www.fda.gov/cder/guidance/1317fnl.pdf
- Homann , M. J. , Vail , R. B. , Previte , E. , Tamarez , M. , Morgan , B. , Dodds , D. and Zaks , A. 2004 . Rapid identification of enantioselective ketone reductions using targeted microbial libraries . Tetrahedron , 60 : 789 – 797 .
- Bornscheuer , U. T. and Kazlauskas , R. J. 1999 . Hydrolase in Organic Synthesis Regio‐and Stereoselective Biotransformation Weinheim : Wiley‐VCH .
- Lieses , A. , Seelbach , K. and Wandrey , C. 2000 . Industrial Biotransformation Weinheim : Wiley‐VCH .
- Faber , K. 2000 . Biotransformation in Organic Chemistry , 4th ed. Ber : Springer .
- Matsuda , T. , Tsuji , K. , Kamitanaka , T. , Harada , T. , Nakamura , K. and Ikariya , T. 2005 . Rate enhancement of lipase‐catalyzed reaction in supercritical carbon dioxide . Chem. Lett. , 34 : 1102 – 1103 .
- Dax , T. , Stanek , M. and Poechlauer , P. WO 2005095628 Al. .
- Daiwang , X. and Zuyi , L. 2003 . Shengming, M. Novozym‐435‐catalyzed enzymatic separation of racemic propargylic alcohols. A facile route to optically active terminal aryl propargylic alcohols . Tetrahedron Lett. , 44 : 6343 – 6346 .
- Cristiano , R. , João , V. C. , Leandro , H. A. and André , L. M. P. 2004 . Kinetic resolution of propargylic and allylic alcohols by Candida antarctica lipase (Novozyme 435) . Tetrahedron Asym. , 15 : 3117 – 3122 .
- Sajja , H. K. , Mattias , P. and Uwe , T. B. 2002 . Enantioselective transesterification of a tertiary alcohol by lipase A from Candida Antarctica . Tetrahedron Asym. , 13 : 2693 – 2696 .
- Hong , Y. , Erik , H. and Uwe , T. B. 1999 . Highly efficient double enantioselection by lipase‐catalyzed transesterification of (R,S)‐carboxylic acid vinyl esters with (RS)‐1‐phenylethanol . Tetrahedron Asym. , 10 : 957 – 960 .
- Nassima , B. , Hanane , D. , Louisa , A. Z. and Fiaud , J. C. 2004 . On the use of succinic anhydride as acylating agent for practical resolution of aryl–alkyl alcohols through lipase‐catalyzed acylation . Tetrahedron Lett. , 45 : 627 – 630 .